Search by Drug Name or NDC

    NDC 00310-0625-60 KOSELUGO 25 mg/1 Details

    KOSELUGO 25 mg/1

    KOSELUGO is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AstraZeneca Pharmaceuticals LP. The primary component is SELUMETINIB.

    Product Information

    NDC 00310-0625
    Product ID 0310-0625_6c8f682f-896f-4f33-9edc-97c152c1f452
    Associated GPIs 21533565500125
    GCN Sequence Number 080922
    GCN Sequence Number Description selumetinib/vitamin E TPGS CAPSULE 25 MG ORAL
    HIC3 V3U
    HIC3 Description ANTINEOPLASTIC - MEK1 AND MEK2 KINASE INHIBITORS
    GCN 47909
    HICL Sequence Number 046451
    HICL Sequence Number Description SELUMETINIB SULFATE/VITAMIN E TPGS
    Brand/Generic Brand
    Proprietary Name KOSELUGO
    Proprietary Name Suffix n/a
    Non-Proprietary Name SELUMETINIB
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 25
    Active Ingredient Units mg/1
    Substance Name SELUMETINIB
    Labeler Name AstraZeneca Pharmaceuticals LP
    Pharmaceutical Class Kinase Inhibitor [EPC], Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA], Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA213756
    Listing Certified Through 2024-12-31

    Package

    NDC 00310-0625-60 (00310062560)

    NDC Package Code 0310-0625-60
    Billing NDC 00310062560
    Package 60 CAPSULE in 1 BOTTLE (0310-0625-60)
    Marketing Start Date 2020-04-16
    NDC Exclude Flag N
    Pricing Information N/A